Abstract

  Bumetanide is a potent diuretic. It acts by blocking NKCC-1 cation - chloride co-transporter. The purpose of the present review work is to highlight different analytical methods available for Bumetanide estimation in pharmaceutical preparations and biological samples. Analytical methods such as UV, HPLC HPTLC, GC-MS, LC-MS etc were found from the literature.

Keywords: Bumetanide; HPLC; Methanol; Helium

References

1. Flamenbaum W., et al. “Pharmacology, therapeutic efficacy, and adverse effects of Bumetanide, a new loop diuretic”. Pharmacotherapy 2 (1982): 213-222.
2. Chaitanya B and Raja S. “Method development and validation of Bumetanide by UV spectrophotometric method in bulk and pharmaceutical dosage form”. European Journal of Biomedical and Pharmaceutical Sciences 5.3 (2018): 443-450.
3. Annapurna MM., et al. “New spectrophotometric methods for the quantification of Bumetanide tablets”. Acta Scientific Pharmaceutical Sciences 3.8 (2019): 91-95.
4. Abd-Elzaher MM., et al. “Characterization of Eu (III) complex for determination of Bumetanide in pharmaceutical preparations and in biological fluids”. Egypt Journal of Chemistry 59.5 (2016): 701-718.
5. Annapurna MM., et al. “New Stability Indicating RP-UFLC Method for the Determination of Bumetanide - A Potent Diuretic”. Acta Scientific Pharmaceutical Sciences 3.8 (2019): 84-90.
6. Rao JR., et al. “Stability indicating RP-HPLC method for Bumetanide in bulk drug and tablet formulation”. Asian Journal of Research in Chemistry 2.3 (2009): 266-269.
7. Huang Q., et al. “HPLC Determination of the dissolution of Bumetanide tablets”. Chinese Journal of Pharmaceutical Analysis 27.8 (2007): 1285-1287.
8. Zivanov SD., et al. “High-performance liquid chromatographic method for the determination of Bumetanide in pharmaceutical preparations”. Journal of Pharmaceutical and Biomedical Analysis 7.2 (1989): 1889-1892.
9. Seethi R., et al. “Development and validation of RP-HPLC for estimation of Bumetanide in tablet formulation”. Indian Journal of Field Veterinarians 9.4 (2014): 46-53.
10. Suresh KP., et al. “RP-HPLC estimation of Bumetanide and its impurities oral solid dosage form”. Asian Journal of Chemistry 31.10 (2019): 2215-2221.
11. Kun T. “Content determination of principal agents in Bumetanide tablets by HPLC-Flourimetry”. China Pharmacy 19 (2005): 1493-1494.
12. Guo-qin W., et al. “Determination of dissolution of Bumetanide tablets by HPLC”. Strait Pharmaceutical Journal 9 (2007): 34-36.
13. Bu-juan Y. “Determination of Bumetanide in Bumetanide tablets by HPLC”. China Medical herald 26 (2008): 31-32.
14. Bao-qiang R. “Determination of Bumetanide tablets by HPLC”. Strait Pharmaceutical Journal 1 (2006): 77-78.
15. Dong-ming P., et al. “Determination of Bumetanide for injection by HPLC”. Chinese Journal of Modern Applied Pharmacy 5 (2006): 404-406.
16. Chaitanya B and Raja S. “Method development, validation and stability studies for determination of Bumetanide in bulk and pharmaceutical dosage form by RP-UPLC”. International Journal of Pharmacy and Pharmaceutical Sciences 10.3 (2018): 35-42.
17. Legorburu M J., et al. “Quantitative Determination of the Loop Diuretic Bumetanide in Urine and Pharmaceuticals by High-Performance Liquid Chromatography with Amperometric Detection”. Journal of Chromatographic Science 39 (2001): 425-430.
18. Ashok KS., et al. “Simultaneous analysis of furosemide and Bumetanide in horse plasma in high performance liquid chromatography”. Biomedical chromatography 3.6 (1989): 262-265.
19. Zhuomin Z., et al. “Determination of diuretics in human urine by hollow fibre-based liquid-liquid microextraction coupled to high performance liquid chromatography”. Analyst 9 (2008): 1187-1194.
20. Cooper SF., et al. “Comprehensive screening procedure for diuretics in urine by high performance liquid chromatography”. Journal of Chromatography B, Biomedical Sciences and Applications 489.1 (1989): 65-88.
21. Guchelaar HJ., et al. “A High Performance liquid chromatographic method for the screening of 21 diuretic in human urine”. Fresenius Journal of Analytical Chemistry 363.7 (1999): 700-705.
22. Wells TG., et al. “Measurement of Bumetanide in plasma and urine by high performance liquid chromatography and application to Bumetanide disposition”. Journal of Chromatography B 570.1 (1991): 235-242.
23. Ameer B and Burlingame MB. “Determination of Bumetanide in human plasma and urine by high performance liquid chromatography with fluorescence detection”. Analytical letters 21.9 (1988): 1589-1601.
24. Walmsley LM., et al. “Determination of Bumetanide in the plasma of non-human primates by high performance liquid chromatography”. Journal of Chromatography B: Biomedical Sciences and Applications 226.2 (1981): 441-449.
25. Hae-Young P., et al. “Determination of Bumetanide in human plasma by a validated HPLC method and its application to its single dose pharmacokinetics”. Journal of Pharmaceutical Investigation 35.1 (2005): 51-55.
26. Deventer K., et al. “Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry”. Biomedical Chromatography 16 (2002): 529-535.
27. Sanz NV., et al. “Determination and characterization of diuretics in human urine by liquid chromatography coupled to pneumatically assisted electrospray ionization mass spectrometry”. Journal of Mass Spectrometry 36.6 (2001): 1-18.
28. Patel DS., et al. “Application of a rapid and sensitive liquid chromatography - tandem mass spectrometry method for determination of Bumetanide in human plasma for bioequivalence study”. Journal of Pharmaceutical and Biomedical Analysis 66 (2012): 365-370.
29. Yijun LI., et al. “Sensitive isotope dilution liquid chromatography/tandem mass spectrometry method for quantitative analysis for Bumetanide in serum and brain tissue”. Journal of Chromatography B Analytical Technologies in Biomedical Life Science 879 (2011): 998-1002.
30. Deventer K., et al. “Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography/mass spectrometry with scan-to-scan polarity switching”. Rapid Communication in Mass Spectrometry 19 (2005): 90-98.
31. Shobha A., et al. “Comprehensive screening of diuretics in human urine using liquid chromatography tandem mass spectrometry”. Analytical Chemistry an Indian Journal 13.7 (2013):270-283.
32. Sachin D., et al. “An ultra-fast and sensitive detection of 165 drugs of abuse in human urine using polarity switching ultra-performance liquid chromatography tandem mass spectrometry”. Analytical Chemistry an Indian Journal 15.8 (2015): 319-338.
33. John OT., et al. “A high-throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS/MS”. Journal of Mass Spectrometry 43 (2008): 980-992.
34. Gong XU., et al. “Determination of 37 illegally added in weight losing, lipid lowering and laxative health foods by UPLC-MS/MS”. Chinese Journal of Pharmaceutical Analysis 36.5 (2016): 918-928.
35. Lisi AM., et al. “Screening of diuretics in human urine by gas chromatography-mass spectrometry with derivatisation by direct extractive alkylation”. Journal of chromatography B: Biomedical Sciences and Applications 563.2 (1991): 257-270.
36. Beyer J., et al. “Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation”. Therapeutic Drug Monitoring 27.4 (2005): 509-520.  
37. Heinz WH and Rudiger S. “Detection of diuretics in horse urine by GC/MS”. Journal of Analytical Toxicology 16.3 (1992): 194-198.
38. Olga Z., et al. “Determination of 8 Diuretics and Probenecid in Human Urine by Gas Chromatography-Mass Spectrometry: Confirmation Procedure”. American Journal of Analytical Chemistry 3.4 (2012): 320-327.
39. Xiuhan Y., et al. “Indirect laser-induced fluorescence detection of diuretics separated by capillary electrophoresis”. Journal of Separation Science 29 (2006): 677-683.
40. Xinyu Z., et al. “A online-field amplification sample stacking method for the determination of diuretics in the urine by capillary electrophoresis - amperometric detection”. Talanta 76.1(2008): 15-20.
41. Gonzalez E., et al. “Direct determination of diuretics drugs in urine by capillary zone electrophoresis using fluorescence detection”. Journal of Chromatography B: Biomedical Science Applications 687.1 (1996): 145-150.
42. Minghua L., et al. “A new method for screening and determination of diuretics by on-line CE-ESI-MS”. Electrophoresis 28 (2007): 1461-1471.
43. Kumar M., et al. “Development and validation of stability indicating HPTLC method for analysis of Bumetanide in bulk drug and tablet dosage form”. Research Journal of Pharmacy and Technology 3.1 (2010): 239-243.
44. Luna T and Olga Z. “Simple and rapid determination of diuretics by luminescent method”. Journal of Pharmacy and Pharmacology 4 (2013): 520-527.

Citation

Citation: Palyam Bhanu and Raja Sundararajan. “A Review of Different Analytical Techniques: Bumetanide". Acta Scientific Pharmaceutical Sciences 4.2 (2020): 60-64.